GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » American Green Inc (OTCPK:ERBB) » Definitions » Common Stock

ERBB (American Green) Common Stock : $0.43 Mil (As of Jun. 2023)


View and export this data going back to . Start your Free Trial

What is American Green Common Stock?

American Green's quarterly common stock stayed the same from . 20 ($0.00 Mil) to Jun. 2022 ($0.00 Mil) but then increased from Jun. 2022 ($0.00 Mil) to Jun. 2023 ($0.43 Mil).

American Green's annual common stock stayed the same from . 20 ($0.00 Mil) to Jun. 2022 ($0.00 Mil) but then increased from Jun. 2022 ($0.00 Mil) to Jun. 2023 ($0.43 Mil).


American Green Common Stock Historical Data

The historical data trend for American Green's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

American Green Common Stock Chart

American Green Annual Data
Trend Jun22 Jun23
Common Stock
- 0.43

American Green Semi-Annual Data
Jun22 Jun23
Common Stock - 0.43

American Green Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.


American Green Business Description

Traded in Other Exchanges
N/A
Address
30 N Gould Street, Suite R, Sheridan, WY, USA, 82801
American Green Inc is a technology company in the medical cannabis industry. It is involved in the business of developing a cultivation facility in Phoenix Arizona for medical marijuana and also owns proprietary dispensing machines and has online sales operation for CBD products and apparel.

American Green Headlines

From GuruFocus

American Green Issues Strategic Corporate Overview

By PRNewswire PRNewswire 12-29-2020